Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2004

View Archived Issues

Medarex to receive milestone payment from Amgen for antibody development

Gilead Sciences and Achillion collaborate on HCV compounds

Dyax grants use of antibody phage display libraries to Tanox

Amendment to terms of Vitex/Panacos merger

Progression of Lipid Sciences' Viral Immunotherapy program

Cardiome selects oral controlled-release formulation of RSD-1235

BioMarin plans phase III trial of Phenoptin for 2005

Medivir and Tibotec enter HCV license and research collaboration agreement

Avidia and Boehringer Ingelheim in development and manufacturing agreement

Bleeding associated with serotonin reuptake inhibition

HER2/ERBB3 pathway implicated in hormone refractory prostate cancer

A new prednisolone formulation shows promise in the treatment of UC

Clinical data on the efficacy of fenretinide in recurrent malignant gliomas

Cognitive benefits found with donepezil in MS patients with verbal memory impairment

Groundbreaking study to explore benefits of long-term pimecrolimus treatment

Good safety profile reported for C31G vaginal gel in healthy volunteers

New compounds for the treatment of psychiatric and mood disorders

Merck claims a series of CGRP receptor antagonists

GABA-A receptor modulators described by NeuroSearch

A series of protein tyrosine phosphatase inhibitors described in a patent

Dual acting compounds for the treatment of psychiatric disorders

Novel MAP kinase/TNF inhibitors in early development at Pfizer

Novartis researchers describe beta2-adrenergic agonists

Antibacterial oxazolidinones claimed by Pfizer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...